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Background: Riboflavin (vitamin B2), the precursor of the flavin cofactors flavin mononucleotide (FMN) and flavin
adenine dinucleotide (FAD), is used commercially as an animal feed supplement and food colorant. E. coli is a
robust host for various genetic manipulations and has been employed for efficient production of biofuels, polymers,
amino acids, and bulk chemicals. Thus, the aim of this study was to understand the metabolic capacity of E. coli for
the riboflavin production by modification of central metabolism, riboflavin biosynthesis pathway and optimization
of the fermentation conditions.
Results: The basic producer RF01S, in which the riboflavin biosynthesis genes ribABDEC from E. coli were
overexpressed under the control of the inducible trc promoter, could accumulate 229.1 mg/L of riboflavin. Further
engineering was performed by examining the impact of expression of zwf (encodes glucose 6-phosphate
dehydrogenase) and gnd (encodes 6-phosphogluconate dehydrogenase) from Corynebacterium glutamicum and
pgl (encodes 6-phosphogluconolactonase) from E. coli on riboflavin production. Deleting pgi (encodes
glucose-6-phosphate isomerase) and genes of Entner-Doudoroff (ED) pathway successfully redirected the carbon flux
into the oxidative pentose phosphate pathway, and overexpressing the acs (encodes acetyl-CoA synthetase) reduced
the acetate accumulation. These modifications increased riboflavin production to 585.2 mg/L. By further modulating
the expression of ribF (encodes riboflavin kinase) for reducing the conversion of riboflavin to FMN in RF05S, the
final engineering strain RF05S-M40 could produce 1036.1 mg/L riboflavin in LB medium at 37°C. After optimizing
the fermentation conditions, strain RF05S-M40 produced 2702.8 mg/L riboflavin in the optimized semi-defined
medium, which was a value nearly 12-fold higher than that of RF01S, with a yield of 137.5 mg riboflavin/g glucose.
Conclusions: The engineered strain RF05S-M40 has the highest yield among all reported riboflavin production
strains in shake flask culture. This work collectively demonstrates that E. coli has a potential to be a microbial cell
factory for riboflavin bioproduction.Background
Riboflavin (vitamin B2) is the universal precursor of flavin
mononucleotide (FMN) and flavin adenine dinucleotide
(FAD), both of which act as hydrogen carriers and are es-
sential for the activity of a wide variety of metabolic en-
zymes in higher eukaryotes [1,2]. Riboflavin is synthesized
by all plants, fungi and most bacteria, but not by higher
animals including humans. So humans and animals must
obtain riboflavin through dietary sources [3]. Traditionally,
riboflavin was synthesized and produced by chemical* Correspondence: zww@tju.edu.cn; chentao@tju.edu.cn
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unless otherwise stated.procedures or microbial fermentation. Since chemical syn-
thesis of riboflavin has many disadvantages such as high
cost and energy wasting, the microbial fermentation
method has been widely applied in industrial production.
Riboflavin biosynthesis has been studied in both gram-
positive and gram-negative bacteria, extensively in Bacillus
subtilis and E. coli. Riboflavin is synthesized from one mol-
ecule of GTP and two molecules of ribulose 5-phosphate
(Ru-5-P) through a seven-step synthetic pathway, which is
similar in all organisms (Figure 1) [4]. Riboflavin has been
produced by the filamentous fungus Ashbya gossypii, the
yeast Candida famata, and the bacterium B. subtilis, all of
which have been developed by using a combined approach
of classical mutagenesis and rational metabolic engineer-
ing [3,5]. Thus, the genetic background of these strains. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Schematic overview of the relevant pathways of riboflavin production and engineering strategies for riboflavin production.
Bacillus subtilis gene names were bracketed. Dashed lines indicate multiple enzymatic steps. The bold lines indicate the overexpression of the
corresponding genes. The × indicates the deletion of the corresponding genes. Enzymes encoded by the genes shown are: pgi, phosphoglucose
isomerase; zwf, glucose 6-phosphate dehydrogenase; pgl, 6-phosphogluconolactonase; gnd, 6-phosphogluconate dehydrogenase; edd, phosphogluconate
dehydratase; eda, multifunctional 2-keto-3-deoxygluconate 6-phosphate aldolase and 2-keto-4-hydroxyglutarate aldolase and oxaloacetate decarboxylase;
ribA, GTP cyclohydrolase II; ribB, 3,4-dihydroxy-2-butanone 4-phosphate synthase; ribD, fused diaminohydroxyphosphoribosylaminopyrimidine deaminase/
5-amino-6-(5-phosphoribosylamino)uracil reductase; ribE, 6,7-dimethyl-8-ribityllumazine synthase; ribC, riboflavin synthase; ribF, bifunctional riboflavin
kinase/FMN adenylyltransferase; acs, acetyl-CoA synthetase. The abbreviated metabolic intermediates are: KDPG, 2-keto-3-deoxy-6-phospho-D-gluconate;
GTP, guanosine-triphosphate; DARPP, 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate; ARPP, 5-amino-6-(5′-phosphoribitylamino)uracil; ArPP,
5-amino-6-(5-phospho-D-ribitylamino)uracil; ArP, 5-amino-6-(D-ribitylamino)uracil; DHPB, 3,4-dihydroxy-2-butanone-4-P; DRL, 6,7-dimethyl-8-(1-D-ribityl)
lumazine; FMN, riboflavin-5'-phosphate; FAD, flavin adenine dinucleotide; TCA, Tricarboxylic acid cycle.
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overproduction was not fully elucidated.
In a series of previous reports, a numbers of conceiv-
able strategies were carried out to develop B. subtilis as
a riboflavin-producing strain after selection for resistance
to different antimetabolites. In B. subtilis, the riboflavin
production was increased by amplifying copies of rib op-
eron or ribA gene [6,7], or by enhancing the energy gener-
ation and reducing the maintenance metabolism [8-10].
Other efforts focused on modulating precursor metabo-
lites supply by increasing the carbon flow through the
pentose phosphate pathway (PP pathway) [11-14], by de-
regulating the gluconeogenesis flux via inactivating the
ccpN [15], or by enhancing the flux of purine synthesis
pathway [16,17].E. coli has been employed for efficient production of
biofuels, amino acids, and bulk chemicals [18-20]. Al-
though wild type E. coli does not accumulate riboflavin
under natural conditions, it may be an efficient host for
the production of riboflavin due to its clear genetic back-
ground, fast-growing, low maintenance metabolism, and
the presence of convenient metabolic engineering tools.
Thus, the aim of this study was to understand the meta-
bolic capacity of E. coli for the production of riboflavin
by modification of central metabolism, riboflavin bio-
synthesis pathway and optimization of the fermenta-
tion conditions.
In this study, the riboflavin synthetic pathway from E. coli
and B. subtilis was constructed and compared in E. coli
MG1655. Then, we examined the impact of overexpressing
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and pgl from E. coli on riboflavin production. Third, the
glycolysis and ED pathway were modified to reroute car-
bon flux to the PP pathway for improving the riboflavin
synthesis. Fourth, the acetate accumulation was reduced by
overexpressing the acs gene. Finally, riboflavin production
was significantly increased by modulating the expression of
ribF. We also optimized the fermentation conditions for
the riboflavin production. The final recombinant strain
RF05S-M40 produced 2702.8 mg/L riboflavin with a yield
of 137.5 mg riboflavin/g glucose under the optimized batch
fermentation condition.
Results and discussion
Construction of riboflavin synthetic pathway
Previous researches indicated that overexpression of
the genes of the riboflavin synthetic pathway contrib-
uted to the efficient production of riboflavin. In B. sub-
tilis, introduction of multiple copies of rib operon into
the chromosome resulted in improving the riboflavin
production [7]. In Pichia pastoris, overexpression of the
riboflavin biosynthetic pathway caused riboflavin pro-
duction increased to 175 mg/L riboflavin although the
wild type P. pastoris did not accumulate riboflavin [21].
In C. famata, overexpressing the gene related to the
riboflavin production significantly increased riboflavin
production [22].Figure 2 Performance of riboflavin biosynthesis pathway with differe
p20C, p15C and p5C have pBR322, p15A and pSC101 replication origin, res
BSribA, BSribB, BSribD, BSribE, BSribC genes are cloned from B. subtilis. Trc,
represent riboflavin yield (mg riboflavin/g-consumed glucose). Symbols rep
measurements from three independent experiments.As shown in Figure 1, the genes of the riboflavin syn-
thetic pathway (ribA, ribB, ribD, ribE, ribC) from E. coli
were assembled into an artificial operon called EC10,
under the control of the inducible trc promoter (Ptrc).
Since the enzymatic activity of GTP cyclohydrolase II and
3, 4-dihydroxy-2-butanone 4-phosphate synthase played a
critical role in riboflavin biosynthesis [21-23], the corre-
sponding encoding genes ribA and ribB from E. coli were
rearranged as the first and second genes in the operon. To
test the dosage effect of the operon on riboflavin produc-
tion, EC10 was inserted into plasmids with different copy
numbers, generating p5C-EC10, p15C-EC10 and p20C-
EC10, which have pSC101, p15A and pBR322 replication
origin, respectively. Wild type E. coli MG1655, harboring
p5C-EC10, p15C-EC10 and p20C-EC10, produced
50.5±1.2, 88.6±7.0 and 229.1±5.7 mg/L riboflavin (Figure 2),
respectively. These results indicated that higher copy
number of riboflavin synthetic genes was beneficial for
riboflavin overproduction, which was in accordance with
previously published results [3,7].
The traditional gene names are different in E. coli and B.
subtilis (Figure 1). For consistency, we use the E. coli gene
names throughout. Thus, the B. subtilis ribA, ribD, ribH,
ribE genes are renamed to ribB/A, ribD, ribE, ribC, re-
spectively (Figure 1). To test the productivity of the ribo-
flavin pathway from B. subtilis, plasmid p20C-BSrib was
constructed by directly inserting the native rib operonnt plasmid replication origin and gene source. Plasmid backbone
pectively. ribA, ribB, ribD, ribE, and ribC are genes cloned from E. coli;
Trc promoter. Gray bars represent riboflavin titer (mg/L). Blank bars
resent the mean values for each parameter ± standard deviation of
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boring p20C-BSrib produced 200.5±7.1 mg/L riboflavin
(Figure 2). Moreover, to construct a synthetic operon de-
void of native regulation, the riboflavin pathway genes
from B. subtilis were individually amplified, rearranged ac-
cording to the order in the metabolic pathway (BSrib(B/A)
DEC), and assembled into p20C, creating plasmid p20C-
BS15. E. coli MG1655 harboring p20C-BS15 produced
180.3±5.6 mg/L riboflavin (Figure 2), which was slightly
lower than that of p20C-BSrib. Moreover, the activities of
key enzymes of riboflavin synthesis, GTP cyclohydrolase II
and riboflavin synthase in MG1655(p20C-BS15) were
lower than that in MG1655(p20C-BSrib) (Table 1). This
phenomenon may be due to that the internal promoters of
native rib operon were removed after rearranging the gene
order [24], which led to a decrease in the expression level
of key genes ribB/A and ribC. Among all the tested rib
gene expressing plasmids, p20C-EC10 showed the highest
riboflavin productivity. Thus, strain RF01S (MG1655 har-
boring p20C-EC10) was selected for further engineering.
Effects of zwf, gnd, and pgl overexpression on riboflavin
production
Ribulose 5-phosphate is an important precursor for ribo-
flavin biosynthesis. Overexpressing the genes of oxidative
PP pathway increased the ribulose 5-phosphate supply
and improved riboflavin production by 31% in B. subtilis
[13]. Mutant genes zwf (A243T) [25] and gnd(S361F) [26] from
C. glutamicum, which encode glucose 6-phosphate de-
hydrogenase and 6-phosphogluconate dehydrogenase with
removal of feedback inhibition, were co-overexpressed by
introducing plasmid p15Trc-zg into RF01S. As shown in
Table 2, the enzyme activities of glucose 6-phosphate de-
hydrogenase and 6-phosphogluconate dehydrogenase
were significantly increased. However, the resulting strain
showed only a slight increase in riboflavin titer and yield,
compared to that harboring p15Trc (Table 2). Due to the
low endogenous activity of 6-phosphogluconolactonase in
E. coli [27,28], we further overexpressed pgl (encoding 6-
phosphogluconolactonase) from E. coli along with zwf and
gnd by transforming p15Trc-zgp into RF01S, which led to
an increase of 18.9% and 38.7% in riboflavin titer andTable 1 Activities of GTP cyclohydrolase II and Riboflavin
synthase
Strain/Plasmid Enzyme activities (nmol/min/mg protein)
GTP cyclohydrolase IIa Riboflavin synthaseb
E. coli MG1655/p20C-EC10 8.6±0.4 14.3±1.6
E. coli MG1655/p20C-BSrib 6.4±0.3 10.9±0.4
E. coli MG1655/p20C-BS15 6.3±0.2 9.6±0.4
aOne unit of enzyme activity catalyzes the formation of 1 nmol of 2,5-diamino-
6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate per min.
bOne unit of enzyme activity catalyzes the formation of 1 nmol of riboflavin
per min.yield, compared to that harboring p15Trc (Table 2). How-
ever, compared to strain RF01S, overexpressing PP path-
way genes did not significantly increase the riboflavin
production, possibly because of the complex regulation of
central metabolic pathway [29] and a high metabolic bur-
den of heterologous protein production [30].Disruption of pgi for improving riboflavin production
Based on the results of overexpressing the genes of PP
pathway, the strategy of eliminating competitive pathway
for redirecting the carbon flux into the oxidative PP
pathway was employed to improve the riboflavin pro-
duction. The disruption of pgi encoding phosphoglucose
isomerase resulted in a blocked entry into glycolysis and
compelled glucose 6-phosphate to be metabolized exclu-
sively through PP pathway [31]. Thus, we disrupted pgi
in MG1655, creating RF02. RF02 harboring p20C-EC10
(RF02S) accumulated 394.8±19.6 mg/L riboflavin, which
was 72.4% higher than that of the reference strain RF01S
(Table 3). In accord with previous studies, the Δpgi mu-
tant strains showed strongly reduced glucose uptake
rates and maximum specific growth rate [32]. One pos-
sible reason for this phenomenon was that the Δpgi mu-
tation would result in high glucose 6-phosphate pool
and led to the rapid degradation of ptsG mRNA, an im-
portant member of the PTS transport systems, which
would decrease the glucose uptake capacity [33]. More-
over, the Δpgi mutation also diminishes the supply of
PEP needed for PTS-mediated uptake of glucose and de-
creases the growth rate [34].Disruption of edd and eda for improving riboflavin
production
The ED pathway has been shown to be inactive with glu-
cose as the carbon source in wild-type E. coli [35], but it
was activated in the pgi mutant strain [31]. Previous
studies indicated that glucose was mainly metabolized
through PP pathway and partially through ED pathway
after pgi was disrupted [36].
The edd and eda transcription levels in the Δpgi strain
RF02 were compared with parent strain MG1655 through
RT-qPCR analysis. Consistent with previously research
[37], the transcript abundance of edd and eda increased
2.21-fold and 2.36-fold in RF02, respectively, which indi-
cated that ED pathway was up-regulated in Δpgi strain.
Thus, edd and eda were disrupted in RF02 for further in-
creasing the flux from 6-phosphogluconate to Ru-5-P,
resulting in strain RF03. RF03 harboring p20C-EC10
(strain RF03S) produced 559.88±8.99 mg/L riboflavin,
which increased by 41.8% compared to that of RF02S
(Table 3). These results suggested that further increasing
riboflavin precursors can be achieved via disrupting ED
pathway in the pgi mutation strain.





Enzyme activity (nmol/min/mg protein)c
G6PDH d 6PGDHd
RF01S/p15Trc 3.8±0.1 192.1±7.3 23.0±0.9 111.5±11.5 119.1±8.4
RF01S/p15Trc-zg 3.0±0.1 197.4±9.2 24.2±1.4 203.6±18.5 174.7±14.2
RF01S/p15Trc-zgp 3.1±0.1 228.4±0.9 31.9±1.3 199.0±20.0 177.1±17.6
aOD600 is the final optical density of the culture.
bmg/g: mg/g-consumed glucose.
Batch cultures of recombinant strains were carried out in LB medium containing 10 g/L glucose at 37°C as described in methods. Standard deviations were
calculated from the results of three independent experiments.
cOne unit of the enzyme activity was defined as the amount catalyzing the formation of 1 nmol of NADPH per min. Results are the mean values of
three measurements.
d6PGDH, 6-phosphogluconate dehydrogenase; G6PDH, glucose 6-phosphate dehydrogenase.
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production
Acetate, which led to growth retardation, was the main
byproduct of these recombinant strains. Thus, the strat-
egy of overexpressing the acs gene encoding acetyl-CoA
synthetase was selected to reduce acetate secretion. The
trc promoter was inserted in the upstream of acs gene in
RF03, resulting in strain RF05. RT-qPCR analysis showed
that the expression of acs gene in RF05S (RF05 harboring
p20C-EC10) increased 4.80-fold compared with RF03S,
indicating successful overexpression of acs gene. RF05S
produced 585.2±13.6 mg/L riboflavin with a yield of
59.30 mg/g glucose, which did not change significantly
compared to RF03S (Table 3). However, the acetate pro-
duction decreased from 4.0 g/l to 1.5 g/L in strain
RF05S, which was in accordance with the results pre-
sented by Lin et al. [38].
Modulating the expression ribF for enhanced riboflavin
production
According to previous studies, introducing a mutation in
ribC gene (encoding flavokinase/flavin adenine dinucleo-
tide synthetase) in B. subtilis could reduce enzymatic ac-
tivity and resulted in riboflavin overproduction in the
engineering strains [39]. The ribC mutation of B. subtilis
also reduced the synthesis of FMN, which is a negative
regulatory factor of rib operon transcription [40]. In E. coli,
these enzymes were encoded by ribF, which is an essential
gene for strain growth [41]. Therefore, we speculate thatTable 3 Riboflavin production of the various strains construct
Strain OD600a Biomass (g/L)b Riboflavin (mg/L) R
RF02S 5.4±0.3 2.0±0.1 394.8±9.6 3
RF03S 5.2±0.4 1.9±0.1 559.9±8.9 5
RF05S 4.9±0.2 1.8±0.1 585.2±13.6 5
aOD600 is the final optical density of the culture.
bThe average cell dry weight for all of the strains was 0.38 g/L per optical-density (O
cmg/g: mg riboflavin/g-consumed glucose.
Batch cultures of recombinant strains were carried out in LBG medium (LB with 10
calculated from the results of three independent experiments.reducing the expression level ribF might reduce the
conversion of riboflavin to FMN/FAD and increase ribo-
flavin production.
To modulate the expression of ribF, we designed a li-
brary of RBS sequences with varied strengths weaker
than that of the native ribF RBS using RBS calculator
[42]. Then, the native RBS of ribF on the chromosome
of RF05S was replaced with the designed RBS library
using the method described in methods. Forty three mu-
tants were selected and transformed with p20C-EC10 to
screen for enhanced riboflavin producer. Riboflavin pro-
duction of the selected strains was measured after 48 h
cultivation in LB medium with 10 g/L glucose at 37°C in
flasks. The majority of the selected strains exhibited in-
creased riboflavin production compared with the parent
strain (Figure 3), which demonstrated that modulating
ribF expression could efficiently increase riboflavin pro-
duction. Strain RF05S-M40 produced 1036.1±54.6 mg/L
riboflavin, which was the highest among all selected
strains, and was 77.0% higher than that of RF05S. Repre-
sentative profiles of riboflavin production, biomass accu-
mulation and glucose consumption for the strain RF05S-
M40 were shown in Figure 4A. Flavokinase activity in
cell-free extracts of RF05S was about 1.45±0.09 nmol/
min/mg protein, while that of RF05S-M40 was about
0.94±0.04 nmol/min/mg protein, indicating that the ex-
pression level of flavokinase was decreased by modulating
the RBS of ribF and this reduced expression contributed
much to riboflavin overproduction.ed in the study




D600) unit of culture.
g/L glucose) at 37°C as described in methods. Standard deviations were
Figure 3 Relevant riboflavin production of various RF05S mutants after fine-tuning ribF expression. Strains were cultured in LB media
with 10 g/L glucose at 37°C. Standard deviations were calculated from the results of three independent experiments.
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production
To optimize fermentation condition, we investigated the
effect of different culture temperatures on riboflavin
production. Changing the fermentation temperature from
37°C to 31°C increased riboflavin titer to 1507.0±56.8 mg/L
from 1036.1±54.6 mg/L (Figure 4B). Many factors may
have contributed to the enhanced production. For example,
growth temperature was reported to influence not only re-
combinant gene expression and protein folding, but also
the global metabolism of the strains [43]. In addition, low
growth temperature was reported to stabilize the recom-
binant proteins and improve the plasmid stability [44].
We further evaluated the riboflavin production of
RF05S-M40 in semi-synthetic medium. Two different semi-
synthetic medium formulations, M9 minimal medium
and MS medium, were tested with different concentration
of yeast extract at 37°C or 31°C (Table 4). When cells were
cultivated in M9 minimal medium with 1 g/L yeast extract
at 37°C, cell growth was severely hampered (OD 600 of 4),
leading to a titer of 271.8±4.9 mg/L riboflavin (Table 4).
Switching to another defined semi-synthetic medium (MSmedium) led to much higher titers (Table 4). Using MS
medium with 5 g/L yeast extract as culture medium ex-
hibited the highest productivity in shake flask culture at
31°C. Optimization of the composition of MS medium
further increased riboflavin production. Detailed compos-
ition of the optimized MS medium and riboflavin produc-
tion profile were shown in Additional file 1: Table S2.
Statistical analysis indicated that the adding of glycine in
the medium contributed significantly to riboflavin over-
production. The reason for the increase in the riboflavin
production might be that the supplement of glycine,
which is an important purine precursor and is incorpo-
rated into the riboflavin molecule, enhanced the availabil-
ity of GTP and thus improved the riboflavin production
[45]. Similar phenomenon has been reported in A. gossypii
and C. famata [46].
The time profiles of cell growth, glucose consumption
and riboflavin production in the non-optimized medium
and the optimized medium were shown in Figure 5. A
maximal cell density was attained and residual glucose was
almost exhausted after 60 h culture. A maximal riboflavin
production reached 2702.8±89.9 mg/L using the optimized
Figure 4 Time-course profiles of riboflavin production, biomass accumulation and glucose consumption of RF05S-M40 in different
temperatures. Strains were cultured in LB media at 37°C (A) and 31°C (B). Symbols represent the mean values for each parameter ± standard
deviation of measurements from three independent experiments.
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shake flask cultivation, which was 2-fold higher than that
of non-optimized medium. The final titer and specific
production rates of RF05S-M30 were still lower than that
of the industrial producers such as A. gossypii, C. famata,
B. subtilis, and Corynebacterium ammoniagenes, which up
to 20 g/L riboflavin can be reached with specific production
rates of 20.7 mg/g CDW/h in industrial fed-batch produc-
tion processes [5,13,47]. However, the yields of these indus-
trial producers were lower than that of the recombinant E.Table 4 Riboflavin production of RF05S-M40 in different cultu




M9 37 3 7.0±0.1
M9 37 5 6.8±0.1
MS 37 1 6.4±0.1
MS 37 3 6.3±0.2
MS 37 5 7.7±0.3
M9 31 5 7.7±0.2
MS 31 1 6.5±0.2
MS 31 3 7.3±0.2
MS 31 5 7.6±0.2
aOD600 was the final optical density of the culture.
bThe average cell dry weight for all of the strains was 0.38 g/L per optical-density (O
cmg/g: mg riboflavin/g-consumed glucose.
dBatch cultures of RF05S-M40 was carried out in modified M9 or MS containing 10
results of three independent experiments.coli (e.g. 0.138 for RF05S-M40 versus 0.100 g riboflavin/g
glucose for C. famata [22,47]). In addition, the specific
glucose uptake rate of RF05S-M40 was still very low.
Therefore, improving the glucose uptake rate could be
an effective approach to further improving riboflavin pro-
duction in RF05S-M40. Moreover, several published re-
ports have shown that enhancing the availability of GTP
increased the production of in B. subtilis and A. gossypii
[16,17,48,49], and thus further engineering the purine
pathway might be a possible target for enhancing riboflavinral conditions




1.6±0.1 271.8±4.8 66.4±8.6 3.6±0.2
2.7±0.1 289.5±7.9 25.2±0.8 2.3±0.1
2.7±0.1 532.4±24.9 50.7±0.6 4.3±0.2
2.4±0.1 702.4±17.4 66.0±0.7 6.1±0.2
2.4±0.1 811.2±43.8 79.7±2.3 7.1±0.5
2.9±0.1 847.4±38.0 82.7±3.2 6.1±0.4
2.9±0.1 892.5±23.1 84.3±3.8 6.4±0.3
2.1±0.1 577.6±11.4 66.5±1.9 4.9±0.2
2.8±0.1 907.7±12.8 93.1±2.3 6.8±0.2
2.9±0.1 1204.1±40.4 120.6±5.4 8.7±0.4
D600) unit of culture.
g/L glucose at 31°C or 37°C. Standard deviations were calculated from the
Figure 5 Time-course profiles of riboflavin production, biomass accumulation and glucose consumption of RF05S-M40 in diferent
mediums. Strains were cultured in the non-optimized MS medium (A) and optimized MS medium (B). Symbols represent the mean values for
each parameter ± standard deviation of measurements from three independent experiments.
Table 5 Strains used in this study
Strain Characteristics Source
Escherichia coli DH5α Coli Genetic Stock Center strain
(CGSC) No. 12384
CGSCa
E. coli MG1655 Coli Genetic Stock Center strain
(CGSC) No. 7740
CGSC
Bacillus subtilis 168 Wild type Lab collection
RF01S E. coli MG1655 containing
p20C-EC10
This study
RF02 E. coli MG1655, Δpgi This study
RF02S RF02containing p20C-EC10 This study
RF03 E. coli MG1655, Δpgi, Δedd, Δeda This study
RF03S RF03 containing p20C-EC10 This study
RF05 E. coli MG1655, Δpgi, Δedd, Δeda,
Ptrc-acs
This study
RF05S RF05 containing p20C-EC10 This study
aColi Genetic Stock Center.
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[47], the fermentation strategy used in our research is
much rougher. The riboflavin titer and productivity of the
strain constructed in this work could be further increased
by fed-batch fermentation optimization.
Conclusions
For the first time, we constructed a genetically defined
riboflavin producing E. coli strain. Riboflavin synthetic
pathway, PP pathway, central metabolic pathways, and
riboflavin consumption pathway were systematically
engineered for direct and efficient conversion of glucose
to riboflavin. The E. coli strain RF05S-M40 has the
highest yield among all reported riboflavin production
strains in shake flask culture. This work also demon-
strates that E. coli has a potential to be a host for ribo-
flavin bioproduction.
Methods
Strain, medium, and cultivation condition
E. coli K-12 MG1655 (Coli Genetic Stock Center) was se-
lected for engineering of the basic riboflavin-producing
strains using a unique gene manipulate method. All strains
used in this study are summarized in Table 5. E. coli DH5α
was used for the propagation of vector DNA. During strain
construction, cultures were grown at 30°C or 37°C in
Luria-Bertani (LB) broth (per liter: 10 g tryptone, 5 g yeast
extract, 10 g sodium chloride) and supplemented with an-
tibiotics as appropriate.Plasmid construction
For the construction of p5C-EC10, p15C-EC10 and p20C-
EC10 plasmids, structural genes, including ribA, ribB, ribD,
ribE, and ribC, were amplified by PCR with oligonucleotide
primers FuECribA-F, FuECribA-R, FuECribB-F, FuECribB-
R, FuECribD-F, FuECribD-R, FuECribE-F, FuECribE-R,
FuECribC-F, and FuECribC-R using the genomic DNA
of E. coli MG1655 as templates. The five fragments,
were spliced by overlapping extension (SOE)-PCR [50],
constructing E. coli rib operon EC10, which was then
Lin et al. Microbial Cell Factories 2014, 13:104 Page 9 of 12
http://www.microbialcellfactories.com/content/13/1/104cloned into p5C, p15C, p20C between the EcoRI and Hin-
dIII restriction sites. A fragment BSrib containing the
riboflavin operon from B. subtilis was amplified with
oligonucleotide primers BSrib-F/BSrib-R and cloned into
p20C between the EcoRI and BamHI restriction sites, cre-
ating plasmid p20C-BSrib. To construct p20C-BS15 plas-
mid, structural genes, including BDribA, BSribD, BSribH,
BSribE, were amplified by PCR with oligonucleotide
primers FuBSribA-F, FuBSribA-R, FuBSribD-F, FuBSribD-
R, FuBSribH-F, FuBSribH-R, FuBSribE-F and FuBSribE-R
using the genomic DNA of B. subtilis 168 as templates.
The four fragments were spliced by SOE-PCR, construct-
ing BS15. This was then cloned into p20C, obtaining the
expressing plasmid p20C-BS15. Plasmids used were listed
in Table 6.
For the construction of p15Trc-zg, zwf (A243T) and
gnd (S361F) from C. glutamicum were firstly cloned in a
p15A origin vector under the control of Ptrc individually
by CPEC [51] with primer sets p15Trc-1BF, p15Trc-1BR,
p15Trc-zwfF, p15Trc-zwfR, p15Trc-gndF, p15Trc-gndR
respectively. Then, the zwf (A243T) and gnd(S361F) genes
from C. glutamicum and pgl gene from E. coli were assem-
bled into a p15A origin vector under the control of Ptrc
by CPEC, obtaining plasmid p15Trc-zgp. All primers were
listed in Additional file 1: Table S1, and plasmids con-
structed were listed in Table 6.
Genome engineering: gene deletion, replacement, and
insertion
The strategy of fragment construction and genome ma-
nipulation is outlined in Figure 6. The fragments wereTable 6 Plasmids used in this study
Plasmid Characteristicsa
pUC18-SVG pUC18 PvegI-gnd361, Amp
r, Spcr
pUC18-SVZ pUC18 PvegI-zwf243, Amp
r, Spcr
p5C Expression vector, pSC101 replication, Ptrc, Amp
p15C Expression vector, p15A replication, Ptrc, Ampr
p20C Expression vector, pBR322 replication, Ptrc, Ampr
p5C-EC10 pSC101 replication, Ampr, Ptrc-synRBS-ribA-synRB
p15C-EC10 p15A replication, Ampr, Ptrc-synRBS-ribA-synRBS-r
p20C-EC10 pBR322 replication, Ampr, Ptrc-synRBS-ribA-synRB
p20C-BS15 pBR322 replication, Ampr, Ptrc-synRBS-ribB/A-synR
p20C-BSrib pBR322 replication, Ampr, Ptrc-BSrib operon
p15Trc Expression vector, p15A replication, Cmr
p15Trc -zg p15A replication, Cmr, Ptrc-synRBS-zwf-synRBS-gn
p15Trc -zgp p15A replication, Cmr, Ptrc-synRBS-zwf-synRBS-gn
C. glutamicum, pgl gene from E. coli
pTKS/CS p15A replication, Cmr, Tetr, I-SceI restriction sites
pTKRED pSC101 replication, temperature sensitive replica
Red recombinase expression plasmid, lac-inducib
aAbbreviations: Amp ampicillin, Cm chloramphenicol, Km kanamycin, Tet tetracyclineamplified in three rounds of PCR. In the first round of
PCR (Figure 6A), the flanks and the selectable marker
are amplified. E. coli chromosome was used as a PCR
template to amplify the 5′ flank and the 3′ flank of the
target gene. Primers U-F/U-R and L-R/L-F were used to
amplify the 5' homologous arm and the 3' homologous
arm, respectively. The overlapping marker fragments
"tetA-U" and "tetA-L" of the tetA gene were amplified
from pTKS/CS using T2/T-F and T1/T-R primers, re-
spectively (Additional file 1: Table S1). The 5′extensions
for primers U-R and L-F, containing I-sceI recognition
site and 30 bp DR sequence, were complementary to
the T-F and T-R primer sequences, respectively. The
length of the homologous arms was 250–500 bp as indi-
cated. The second round of PCR, the 5' homologous
arm and tet-U, the 3' homologous arm and tet-L were
spliced by SOE-PCR, using primer U-F/T2 and T1/L-R,
respectively. The final fragment was constructed using
SOE-PCR with primer U-F/L-R and electroporated into
target cells carrying pTKRED, according to the method
of Kuhlman [52]. Firstly, a linear fragment consisting of
tetA cassette flank by duplication regions (DRs) and I-
SceI recognition sites was used to replace or insert into
target site for obtaining an intermediate strain. The
tetracycline resistance mutants were selected and con-
firmed by PCR. Then, arabinose was added to induce I-
SceI endonuclease expression for cleaving the tetA and
facilitating the recombination between DRs. The loss of
tetA in the desired recombinant strains were selected
on L-arabinose plates and verified by PCR. This method






S-ribB- synRBS-ribD-synRBS-ribE-synRBS-ribC This study
ibB-synRBS- ribD-synRBS-ribE-synRBS-ribC This study
S-ribB- synRBS-ribD-synRBS-ribE-synRBS-ribC This study
BS-ribD- synRBS-ribE-synRBS-ribC This study
This study
Lab collection
d, zwf and gnd genes from C. glutamicum This study
d-synRBS-pgl, zwf and gnd genes from This study
[52]




Figure 6 Strategies for scarless chromosomal gene deletion, promoter replacement and RBS fine-tuning. (A) Genome editing cassettes
are constructed by three rounds of PCR and recombinants after the first round of recombineering were selected by Tetr. (B) In the second step,
the TetA marker were released by simultaneous induction of I-SceI and Red recombinase expression. (C) The genetic construct for promoter
replacement after the first round of recombination. DR for duplicate region; I-sceI, I-SceI endonuclease recognition site.
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ribF. The primers used during construction are listed in
Additional file 1: Table S1.
As mentioned above, the strategy of fragment construc-
tion and genome manipulation was used to modulate the
expression of ribF. The sequence of primer ribF L_F is
TACAAGGTATACTCGGACGATTTTCACTGTHKTGWR
CCAGMCATG. The RBS library of ribF, design with RBS
Calculator [42], was placed between the DR sequence
(italicized) and the start codon of ribF (bold). The primers
used during construction were listed in Additional file 1:
Table S1.
Quantitative real-time reverse transcription (RT)-PCR
analysis
The recombinant strains were cultured in LB medium with
1% glucose. Cells were harvested when OD600 reached 1.
Total mRNA were extracted using the RNAprep pure
Cell/Bacteria Kit (Tiangen, Beijing, China) as described by
the manufacturer. The cDNA was amplified using Fas-
tQuant RT Kit (Tiangen, Beijing, China) with the total
mRNA as the templates. Samples were then analyzed
using a Light Cycler®480 II (Roche, Basel, Switzerland)
with RealMasterMix (SYBR Green I) (Tiangen, Beijing,
China). Quantity real-time PCR amplification primers
were listed in Additional file 1: Table S1. The rrsA gene
was selected as internal standard for normalization and
three biological replicates were performed. The obtained
data were analyzed by using the 2-ΔΔCt method described
previously [53].Enzyme assay and preparation of cell extracts
The engineering strains were cultivated in LB medium
containing 1% glucose. They were cultured to mid-
exponential phase and the cells were harvested by cen-
trifugation for 10 min at 12000×g and 4°C, washed twice
with 100 mM potassium phosphate (pH 7.5)-1 mM
dithiothreitol-0.1 mM EDTA. The cells were resus-
pended and sonicated for 5 min in an ice bath (130 W,
20 kHz, pulse: 5 s on; 5 s off ). After centrifugation
(13,000×g, 10 min, 4°C), the supernatants were used as
cell extracts. When necessary, IPTG was used at a con-
centration of 2 mM for induction. The activities of GTP
cyclohydrolase II, riboflavin synthase and flavokinase
activity were measured as previously described [54-56].
The activities of glucose 6-phosphate-1-dehydrogenase
and 6-phosphogluconate dehydrogenase were deter-
mined as previously described [57]. Total protein con-
centrations were determined by the Bradford method
using bovine serum albumin as standard [58].
Production of riboflavin from glucose
For riboflavin production, LBG medium (LB medium with
1% (W/V) glucose), modified M9 medium, or modified
minimal salt (MS) medium was selected. An amount of
20 g/liter glucose or 10 g/liter glucose was added as the
carbon source except as indicated. The modified M9
medium contained (per liter) 6 g Na2HPO4, 3 g KH2PO4,
1 g NH4Cl, 0.5 g NaCl, 2 mM MgSO4, 0.1 mM CaCl2, and
yeast extract as indicated. The MS medium contained (per
liter) 3.8 g Na2HPO4, 1.5 g KH2PO4, 1.0 g (NH4)2SO4,
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element solution as described in previous studies [59].
For fermentation, transformed strains were cultured
overnight in 5 ml LB media at 37°C, then transferred into
50 ml LB media with 1% (v/v) of the seed culture. This
was cultured to mid-exponential phase at 240 rpm, 37°C,
and frozen at −80°C in 15% glycerol (v/v). The inoculum
was prepared from frozen seed stocks in LB medium
supplemented with 100 mg/L ampicillin, grown to mid-
exponential phase, and then used to inoculate batch cul-
tures with 1% (v/v) of the seed culture, at 37°C or 31°C
as indicated. When appropriate, IPTG was used at a
concentration of 2 mM for induction. For each strain,
three parallel fermentations were performed.
Analytical methods
Cell concentration was calculated from OD 600 nm mea-
surements. Glucose concentration was measured enzymat-
ically using a glucose analyzer (Model-SBA40, Shandong,
China). To determine the concentration of acetate, culture
samples were centrifuged at 12,000×g for 5 min and the
aqueous supernatant used for HPLC analysis on an Agilent
1100 Series HPLC system equipped with an Aminex HPX-
87H anion exchange column (Bio-Rad Laboratories, Rich-
mond, CA, USA) and refractive index detector. The col-
umn was eluted with 5 mM sulfuric acid at a flow rate of
0.4 ml/min. Standards were prepared for acetate for both
the refractive index detector, and calibration curves were
created. For riboflavin measurements, culture samples
were diluted with 0.05 M NaOH to the linear range of
the spectrophotometer and the A444 was immediately
measured. The results represented the means±S.D. of
three independent experiments. Dry cell weight (DCW)
was calculated from the optical density at 600 nm
(1 OD600=0.38 g DCW/L).
Additional file
Additional file 1: Table S1. Primers used in this study. Table S2.
Experimental design for evaluating factors influencing biomass and
riboflavin production.
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